Viewing Study NCT00038961


Ignite Creation Date: 2025-12-24 @ 12:05 PM
Ignite Modification Date: 2026-01-31 @ 9:41 PM
Study NCT ID: NCT00038961
Status: COMPLETED
Last Update Posted: 2016-09-01
First Post: 2002-06-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO).
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Thromboembolism View
Keywords:

Keywords

Keyword Brief Keyword Text View
None fondaparinux sodium View
None DVT Prevention View
None abdominal surgery View
None VTE prevention View
None venous thromboembolism View
None pulmonary embolism View